Risk of pancreatic adenocarcinoma: Disparity between African Americans and other race/ethnic groups

Cancer

Volumn 103, Issue 2, 2005, Pages 349-357

  Chang, Kenneth J ^a   Parasher, Gulshan ^a   Christie, Catherine ^b   Largent, Joan ^b   Anton Culver, Hoda ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

African American; Pancreatic adenocarcinoma epidemiology; Primary pancreatic adenocarcinoma; Race ethnic comparison

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ASIAN; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; ETHNIC AND RACIAL GROUPS; FEMALE; GENDER; HEALTH INSURANCE; HISPANIC; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; UNITED STATES;

ADENOCARCINOMA; ADULT; AFRICAN AMERICANS; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CALIFORNIA; CONTINENTAL POPULATION GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PROBABILITY; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 12344268593     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20771     Document Type: Article

References (16)

1. Ries LA, Wingo PA, Miller DS, et al. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer. 2000;88;2398-2424.
2. Percy C, Van Holten V, Muir C., editors. International classification of diseases for oncology. 2nd ed. Geneva: World Health Organization, 1990.
3. Silverman DT, Hoover RN, Brown LM, et al. Why do Black Americans have a higher risk of pancreatic cancer than White Americans? Epidemiology. 2003;14:45-54.
4. Dalton RR, Sarr MG, van Heerden JA, Colby TV. Carcinoma of the body and tail of the pancreas: is curative resection justified? Surgery. 1992;111:489-494.
5. Pernick NL, Sarkar FH, Philip PA, et al. Clinicopathological analysis of pancreatic adenocarcinoma in African Americans and Caucasians. Pancreas. 2003;26:28-32.
6. Weir HK, Thun MJ, Hankey BF, et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst. 2003;95:1276-1299.
7. Lin RS, Kessler, II, A multifactorial model for pancreatic cancer in man. Epidemiologic evidence, JAMA. 1981;245:147-152.
8. Adami HO, Persson I, Hoover R, Schairer C, Bergkvist L. Risk of cancer in women receiving hormone replacement therapy. Int J Cancer. 1989;44:833-839.
9. Horimi T, Morita S, Takeda I, et al. [Hormone therapy of tamoxifen in resected adenocarcinoma of the pancreas]. Nippon Geka Gakkai Zasshi. 1993;94:730-735.
10. Robles-Diaz G, Duarte-Rojo A. Pancreas: a sex steroid-dependent tissue. Isr Med Assoc J. 2001;3:364-368.
11. Sumi C, Brinck-Johnsen T, Longnecker DS. Inhibition of a transplantable pancreatic adenocarcinoma by castration and estradiol administration in rats. Cancer Res. 1989;49:6687-6692.
12. Sumi C, Longnecker DS, Roebuck BD, Brinck-Johnsen T. Inhibitory effects of estrogen and castration on the early stage of pancreatic carcinogenesis in Fischer rats treated with azaserine. Cancer Res. 1989;49:2332-2336.
13. Lhoste EF, Roebuck BD, Brinck-Johnsen T, Longnecker DS. Effect of castration and hormone replacement on azaserine-induced pancreatic carcinogenesis in male and female Fischer rats. Carcinogenesis. 1987;8:699-703.
14. Taylor OM, Benson EA, McMahon MJ. Clinical trial of tamoxifen in patients with irresectable pancreatic adenocarcinoma: The Yorkshire Gastrointestinal Tumor Group. Br J Surg. 1993;80:384-386.
15. Keating JJ, Johnson PJ, Cochrane AM, et al. A prospective randomized controlled trial of tamoxifen and cyproterone acetate in pancreatic adenocarcinoma. Br J Cancer. 1989;60:789-792.
16. Crowson MC, Dorrell A, Rolfe EB, Fielding JW. A phase II study to evaluate tamoxifen in pancreatic adenocarcinoma. Eur J Surg Oncol. 1986;12:335-336.